Authors: | Brennan, M. F.; Allen, P. J.; Jarnagin, W. R. |
Review Title: | Fifty years of pancreas cancer care |
Abstract: | Resulting from 50 years of innovation, operations for pancreatic neoplasms can now be performed safely, albeit with significant but manageable morbidity. Molecular diagnosis has allowed for the identification of multiple distinct histopathologies with variable natural histories. Observation is now a strategy for selected indolent cysts and some neuroendocrine neoplasms. For ductal pancreatic adenocarcinoma, a long-term cure remains elusive and will require more than surgical resection for meaningful progress. © 2022 Wiley Periodicals LLC. |
Keywords: | cancer chemotherapy; treatment outcome; treatment response; cancer surgery; histopathology; advanced cancer; pancreas cancer; neoadjuvant therapy; pancreatic neoplasms; antineoplastic agent; cancer diagnosis; adenocarcinoma; pancreas; pancreas cyst; carcinoma, pancreatic ductal; pathology; cancer therapy; neuroendocrine tumor; pancreas carcinoma; total quality management; pancreas tumor; long term care; pancreas adenocarcinoma; surgery; clinical observation; neuroendocrine tumors; history of medicine; pancreas islet cell tumor; randomized controlled trial (topic); molecular diagnosis; minimally invasive procedure; pancreas surgery; cancer; humans; human; article |
Journal Title: | Journal of Surgical Oncology |
Volume: | 126 |
Issue: | 5 |
ISSN: | 0022-4790 |
Publisher: | Wiley Blackwell |
Date Published: | 2022-10-01 |
Start Page: | 876 |
End Page: | 880 |
Language: | English |
DOI: | 10.1002/jso.27030 |
PUBMED: | 36087087 |
PROVIDER: | scopus |
PMCID: | PMC9469554 |
DOI/URL: | |
Notes: | Article -- Export Date: 3 October 2022 -- Source: Scopus |